YU4101A - Novel methods for the identification of ligand and target biomolecules - Google Patents

Novel methods for the identification of ligand and target biomolecules

Info

Publication number
YU4101A
YU4101A YU4101A YU4101A YU4101A YU 4101 A YU4101 A YU 4101A YU 4101 A YU4101 A YU 4101A YU 4101 A YU4101 A YU 4101A YU 4101 A YU4101 A YU 4101A
Authority
YU
Yugoslavia
Prior art keywords
identification
peptide
methods
rna
identified
Prior art date
Application number
YU4101A
Other languages
Serbo-Croatian (sh)
Inventor
Torben Halkier
Lene Jespersen
Allan Jensen
Original Assignee
Inoxell A/S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inoxell A/S. filed Critical Inoxell A/S.
Publication of YU4101A publication Critical patent/YU4101A/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides for methods for identification of biologically active biomolecules. In one aspect, a biologically active biomolecule such as RNA or a peptide is identified by incorporating random nucleotide sequences in a scaffold constituted by an enzyme activity modulator, transforming substantially identical host cells with the construct obtained thereby and screening the transformed cells to identify those where a preselected phenotypic trait has been altered. The randomized DNA is subsequently isolated from the phenotypically altered cells and the peptide and/or RNA encoded by the random sequence is determined. In turn, interaction partners which are putative drug targets are identified and isolated by use of the peptide and/or RNA as part of affinity reagents. A preferred scaffold is derived from the potato inhibitor I family of protease inhibitors and exemplified is the barley chymotrypsin inhibitor 2A (Cl-2A). Another aspect relates to the identification of novel enzyme inhibitors by using substantially the same approach, but screening specifically for changes in target enzyme activity. Also disclosed are methods of producing the relevant transformation and expression vectors as well as methods for identifying lead compounds and drug targets for use in drug development. Finally, the invention also includes within its scope a method for the preparation of a medicinal product.
YU4101A 1998-07-20 1999-07-16 Novel methods for the identification of ligand and target biomolecules YU4101A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199800956 1998-07-20
US9486898P 1998-07-29 1998-07-29

Publications (1)

Publication Number Publication Date
YU4101A true YU4101A (en) 2005-06-10

Family

ID=27675497

Family Applications (1)

Application Number Title Priority Date Filing Date
YU4101A YU4101A (en) 1998-07-20 1999-07-16 Novel methods for the identification of ligand and target biomolecules

Country Status (2)

Country Link
YU (1) YU4101A (en)
ZA (1) ZA200100195B (en)

Also Published As

Publication number Publication date
ZA200100195B (en) 2002-01-08

Similar Documents

Publication Publication Date Title
PL346126A1 (en) Novel methods for the identification of ligand and target biomolecules
Pedersen et al. A method for directed evolution and functional cloning of enzymes
US5821063A (en) Methods for sequencing polymers using mass spectrometry
MX9708427A (en) Pancreas-derived serpin.
ATE282717T1 (en) NOVEL METHOD FOR IDENTIFYING CLONES WITH A DESIRED BIOLOGICAL PROPERTY, STARTING FROM AN EXPRESSION GENE BANK
WO2003099999A3 (en) Generation and selection of protein library in silico
KR100204360B1 (en) A method for identifying a polynucleotide molecule having a selected nucleic acid sequence from a library of random or semi-random polynucleotide molecules
AU3365095A (en) High throughput screening method for sequences or genetic alterations in nucleic acids
WO1999036516A3 (en) Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
Jeon et al. Toward protein-cleaving catalytic drugs: Artificial protease selective for myoglobin
WO2002002740A3 (en) Methods and compositions for determining gene function
WO1996036986A1 (en) Methods and apparatus for sequencing polymers with a statistical certainty using mass spectrometry
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
GB9722320D0 (en) Human cell cycle checkpoint proteins
Burgos et al. Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment
Antal et al. Specificity assay of serine proteinases by reverse-phase high-performance liquid chromatography analysis of competing oligopeptide substrate library
WO2003031928A3 (en) Cellular engineering, protein expression profiling, differential labeling of peptides, and novel reagents therefor
YU4101A (en) Novel methods for the identification of ligand and target biomolecules
MX9703475A (en) D-pantolactone hydrolase and gene encoding the same.
WO2002044409A3 (en) Substrate linked directed evolution (slide)
Ishigami et al. The origin of the genetic code
US20040023292A1 (en) Method and reagent for the detection of proteins and peptides
EP0811696A3 (en) Method to obtain nucleotide sequence using randomly primed amplification
WO2001020024A3 (en) Method for determining nucleic and/or amino acid sequences
WO1997001634A3 (en) Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp)